ArticleFrontiers in neurology2023

A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis.

Sofia Sandgren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.